Tutucon oral solution bottle 600 ml

Instructions Tutukon oral solution bottle 600 ml

Composition

active ingredients:

100 ml of solution contain 100 ml of aqueous extract (2:1) obtained from a mixture of medicinal plants: horsetail (Equisetum arvense) 570 mg, red sedge (Spergularia rubra) 330 mg, boldo leaves (Peumus boldus) 280 mg, prickly pear (cactus) fig flower (Opuntia ficus-indica) 170 mg, narrow-leaved ironweed (Sideritis angustifolia) 170 mg, rosemary leaves (Rosmarinus officinalis) 170 mg, ginkgo (Bermuda grass) roots (Cynodon dactylon) 170 mg, lemon balm leaves (Meliss Officiflis) 170 mg; extractant – water;

Excipients: sodium benzoate (E 211), potassium sorbate, anhydrous citric acid, purified water.

Dosage form

Oral solution.

Main physicochemical properties: colorless to slightly yellowish transparent or slightly opalescent liquid with a specific odor.

Pharmacotherapeutic group

Drugs used in urology. Various drugs, including combinations. ATX code G04B X.

Pharmacological properties

Pharmacodynamics.

Combined herbal preparation. Has diuretic, antispasmodic, litholytic, anti-inflammatory, antibacterial, choleretic and antioxidant effects. Promotes the elimination of uric acid, toxins and heavy metal salts from the body.

Pharmacokinetics.

Not applicable.

Indication

In complex therapy: for urolithiasis (urates, oxalates, phosphates, carbonates), cystitis, urethritis, urinary tract spasms, irritable bowel syndrome; for the prevention of urolithiasis after lithotripsy.

Contraindication

Hypersensitivity to the components of the drug.

Interaction with other medicinal products and other types of interactions

Unknown.

Application features

In case of inflammatory kidney diseases, you should definitely consult a doctor. Use the drug with caution in the presence of gastroenteritis, arterial hypertension, and a tendency to seizures of non-epileptic origin.

Use during pregnancy or breastfeeding.

Since the safety of horsetail during pregnancy has not been conclusively proven, pregnant and breastfeeding women should only take the drug if the benefits outweigh the risks.

Ability to influence reaction speed when driving vehicles or other mechanisms

Does not affect.

Method of administration and doses

The drug is taken orally 3 times a day 30 minutes before meals.

Adults and children over 12 years old – 45 ml 3 times a day.

Children aged 7–12 years – 15 ml 3 times a day.

Children aged 5–7 years – 5–10 ml 3 times a day.

Pregnant and breastfeeding women – 20 ml 3 times a day.

The dose and duration of treatment are determined by the doctor individually for each patient.

The course of treatment is usually 2–4 weeks.

If after 6 days of treatment the condition does not improve, you should stop taking the drug and consult a doctor. It is not recommended to take the drug for a long time. If you miss a dose, you should not take a double dose of the drug.

Children.

The drug is not used in children under 5 years of age.

Overdose

No overdose was observed when using recommended doses.

In case of accidental overdose, discontinue use of the drug and consult a doctor. Treatment is symptomatic.

Side effects

Hypersensitivity reactions: allergic reactions (hyperemia, itching, rash, skin edema).

If any adverse reactions occur, treatment should be discontinued and a doctor should be consulted.

Expiration date

3 years.

Storage conditions

Store in the original packaging at a temperature not exceeding 25 °C.

Keep out of reach of children.

Packaging

300 ml or 600 ml of solution in a polypropylene bottle; 1 bottle together with a plastic measuring cup in a cardboard box.

Vacation category

Without a prescription.

Producer

Miguel and Garriga, S.L.

Location of the manufacturer and address of its place of business

S/Joaquin Costa, 18-1, Montgat, Barcelona, 08390, Spain.